Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Requirement of Protein Geranylgeranylation for Chemokine Receptor Signaling and Th17 Cell Function in an Animal Model of Multiple Sclerosis

Frontiers in Immunology(2021)10.3389/fimmu.2021.641188Source: DataRank Database

A Requirement of Protein Geranylgeranylation for Chemokine Receptor Signaling and Th17 Cell Function in an Animal Model of Multiple Sclerosis is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

gen hpa

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.24)OA: goldTopics (57)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Jia Geng ORCID,Eunchong Park ORCID,Quanquan Ding,John Zhou ORCID,Ciana Walcott

Live enrichment

PubMed:33828552 PMC:PMC8019753 OpenAlex:https://openalex.org/W3139175283

NIAID NIH HHS

Grant: R01 AI145930

NIAID NIH HHS

Grant: R01 AI034530

NIAID NIH HHS

Grant: R01 AI110695

National Institutes of Health

Grant: 5R01AI110695-05

Censoring Inflammation by Protein Geranylgeranylation

FWCI

0.24

Citation Percentile

0.5%

Citation Trend

2022

2023

2025

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.641188/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.641188/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.641188/full

journalhttps://doi.org/10.3389/fimmu.2021.641188

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33828552

Fields of Study

Chemokine receptors and signalingImmunotherapy and Immune ResponsesGlycosylation and Glycoproteins Research0301 basic medicine03 medical and health sciences0302 clinical medicineAnimalsCell DifferentiationChemotaxis, LeukocyteEncephalomyelitis, Autoimmune, ExperimentalMiceMultiple SclerosisProtein PrenylationReceptors, ChemokineSignal TransductionTh17 Cells

MeSH Terms

AnimalsCell DifferentiationChemotaxis, LeukocyteEncephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisSignal TransductionProtein PrenylationReceptors, ChemokineMiceTh17 Cells

Keywords

Cell biologyChemokine receptorGeranylgeranylationBiologyCCL21C-C chemokine receptor type 6Heterotrimeric G proteinCCL13ChemokineImmunologySignal transductionImmune systemG proteinBiochemistryPrenylationT cellsAutoimmunityAdaptive Immune ResponseLymphocyte MigrationProtein GeranylgeranylationEncephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisProtein PrenylationCell DifferentiationRC581-607Chemotaxis, LeukocyteMiceAnimalsTh17 CellsReceptors, ChemokineImmunologic diseases. Allergy

Sustainable Development Goals

SDG 3: 3. Good health

A Requirement of Protein Geranylgeranylation for Chemokine Receptor Signaling and Th17 Cell Function in an Animal Model of Multiple Sclerosis

FAIR Checklist

Authors (10)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)